Proteomic Biomarkers of Heart Failure.
Heart Fail Clin
; 14(1): 93-107, 2018 Jan.
Article
em En
| MEDLINE
| ID: mdl-29153204
ABSTRACT
Heart failure (HF) is associated with significant morbidity and mortality. Biomarkers are used to assist clinicians with timely diagnosis, prognosis, and risk prediction of patients for personalized treatment. Using modern proteomic methods such as mass spectrometry, an increasing number of novel biomarkers have been identified that further aid clinicians in the early diagnosis and outcome prediction of HF. This article focuses on the array of common and novel protein-based biomarkers that provide diagnostic and prognostic information in HF.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Proteômica
/
Insuficiência Cardíaca
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article